Treatment options in non-muscle-invasive bladder cancer after BCG failure

Treatment options in non-muscle-invasive bladder cancer after BCG failure

Bladder cancer is the ninth-most prevalent cancer worldwide. Most patients with urothelial cell carcinoma of the bladder present with non-muscle-invasive disease and are treated with bacillus Calmette-Guérin (BCG) intravesical therapy. Many of these patients experience disease recurrence after BCG f...

Full description

Bibliographic Details
Main Authors: Nathan A Brooks, Michael A O'Donnell
Format: Article
Language:English
Published: Wolters Kluwer Medknow Publications 2015-01-01
Series:Indian Journal of Urology
Subjects:
Chemotherapy
interferon
photodynamic therapy
thermochemotherapy
urinary bladder neoplasms
Online Access:http://www.indianjurol.com/article.asp?issn=0970-1591;year=2015;volume=31;issue=4;spage=312;epage=319;aulast=Brooks

Internet

http://www.indianjurol.com/article.asp?issn=0970-1591;year=2015;volume=31;issue=4;spage=312;epage=319;aulast=Brooks

Similar Items